71
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Insulin resistance and inflammation markers in myocardial infarction

, , , , &
Pages 83-90 | Published online: 17 Jun 2013

References

  • PickupJInflammation and activated innate immunity in the pathogenesis of type 2 diabetesDiabetes Care20042781382314988310
  • YuQGaoFMaXLInsulin says NO to cardiovascular diseaseCardiovasc Res20118951652421051417
  • FernándezJMRilcartWInsulin resistance and chronic cardiovascular inflammatory syndromeEndocr Rev20032427830112788800
  • SmitJWRomijnJAAcute insulin resistance in myocardial ischemia: causes and consequencesSemin Cardiothorac Vasc Anesth20061021521916959753
  • AntoinetteMSteffenLJacobsDRelation of C-reactive protein to insulin resistance and cardiovascular risk factors in youthDiabetes Care2005281763176815983332
  • BarrettTDHennanJKMarksRMLucchesiBRC-reactive-protein-associated increase in myocardial infarct size after ischemia/reperfusionJ Pharmacol Exp Ther20023031007101312438521
  • Fernandez-RealJMVayredaMRichartCCirculating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and womenJ Clin Endocrinol Metab2001861154115911238501
  • GeigerPCHancockCWrightDCHanDHHolloszyJOIL-6 increases muscle insulin sensitivity only at superphysiological levelsAm J Physiol Endocrinol Metab200729218421846
  • FrangogiannisNGSmithCWEntmanMLThe inflammatory response in myocardial infarctionCardiovasc Res200253314711744011
  • ColletJPMontalescotGVicautEAcute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortalityCirculation200310839139412860898
  • AlessiMCJuhan-VagueIPAI-1 and the metabolic syndromeArterioscler Thromb Vasc Biol2006262200220716931789
  • Juhan-VagueIMorangePEFrereCThe plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin/insulin levels in men from Europe: the HIFMECH studyJ Thromb Haemost200312322232914629464
  • KryzhanovskyVADiagnosis and treatment of myocardial infarctionK.Phoenix2001
  • KatzANambiSSMatherKQuantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humansJ Clin Endocrinol Metab2000852402241010902785
  • LeclercqIADa Silva MoraisASchroyenBVan HulNGeertsAInsulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequencesJ Hepatol20074714215617512085
  • CefaluWTInsulin resistance: cellular and clinical conceptsExp Biol Med (Maywood)2001226132611368233
  • PapanicolaouDAVgontzasANInterleukin-6: the endocrine cytokineJ Clin Endocrinol Metab2000851331133310720086
  • Nieto-VazquezIFernández-VeledoSde AlvaroCLorenzoMDual role of interleukin-6 in regulating insulin sensitivity in murine skeletal muscleDiabetes2008573211322118796617
  • OpieLHKnuutiJThe adrenergic-fatty acid load in heat failureJ Am Coll Cardiol2009541637164619850204
  • GwechenbergerMMendozaLHYoukerKACardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions circulationCirculation1999995465519927402
  • PravenecMKajiyaTZídekVEffects of human C-reactive protein on pathogenesis of features of the metabolic syndromeHypertension20115773173721357282
  • D’AlessandrisCLauroRPrestaISestiGC-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transportDiabetologia20075084084917279354